(Q44334871)

English

Effects of intracerebroventricular β-funaltrexamine on μ and δ opioid receptors in the rat: dichotomy between binding and antinociception

scientific article published on October 15, 1991

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Effects of intracerebroventricular β-funaltrexamine on μ and δ opioid receptors in the rat: dichotomy between binding and antinociception (English)

reason for preferred rank

most precise value

1 reference

10.1016/0014-2999(91)90715-3

https://api.crossref.org/works/10.1016/0014-2999(91)90715-3

24 October 2022

Effects of intracerebroventricular beta-funaltrexamine on mu and delta opioid receptors in the rat: dichotomy between binding and antinociception (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1666046

24 October 2022

0 references

1 reference

based on heuristic

inferred from title

1 reference

10.1016/0014-2999(91)90715-3

https://api.crossref.org/works/10.1016/0014-2999(91)90715-3

24 October 2022

author name string

Liu-Chen LY

1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Wheeler-Aceto H

3

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

L. Y. Liu-Chen

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1666046

24 October 2022

S. X. Li

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1666046

24 October 2022

H. Wheeler-Aceto

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1666046

24 October 2022

A. Cowan

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1666046

24 October 2022

language of work or name

0 references

publication date

1 October 1991

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

15 October 1991

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1666046

24 October 2022

full work available at URL

https://api.elsevier.com/content/article/PII:0014299991907153?httpAccept=text/xml

1 reference

10.1016/0014-2999(91)90715-3

https://api.crossref.org/works/10.1016/0014-2999(91)90715-3

24 October 2022

https://api.elsevier.com/content/article/PII:0014299991907153?httpAccept=text/plain

1 reference

10.1016/0014-2999(91)90715-3

https://api.crossref.org/works/10.1016/0014-2999(91)90715-3

24 October 2022

European Journal of Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

203

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

195-202

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Effects of stress and beta-funal trexamine pretreatment on morphine analgesia and opioid binding in rats

1

1 reference

10.1016/0014-2999(91)90715-3

https://api.crossref.org/works/10.1016/0014-2999(91)90715-3

24 October 2022

Delta opioid antagonist, naltrindole, selectively blocks analgesia induced by DPDPE but not DAGO or morphine

3

1 reference

10.1016/0014-2999(91)90715-3

https://api.crossref.org/works/10.1016/0014-2999(91)90715-3

24 October 2022

The physiological relevance of low agonist affinity binding at opioid mu-receptors

4

1 reference

10.1016/0014-2999(91)90715-3

https://api.crossref.org/works/10.1016/0014-2999(91)90715-3

24 October 2022

Pre-incubation of guinea-pig myenteric plexus with beta-funaltrexamine: discrepancy between binding assays and bioassays

6

1 reference

10.1016/0014-2999(91)90715-3

https://api.crossref.org/works/10.1016/0014-2999(91)90715-3

24 October 2022

Nicotine protects against mu-opioid receptor antagonism by beta-funaltrexamine: evidence for nicotine-induced release of endogenous opioids in brain

8

1 reference

10.1016/0014-2999(91)90715-3

https://api.crossref.org/works/10.1016/0014-2999(91)90715-3

24 October 2022

Prolonged in vivo antagonism of central mu- and delta-opioid receptor activity by beta-funal trexamine

9

1 reference

10.1016/0014-2999(91)90715-3

https://api.crossref.org/works/10.1016/0014-2999(91)90715-3

24 October 2022

Mu-type opioid receptors in rat periaqueductal gray-enriched P2 membrane are coupled to guanine nucleotide binding proteins

10

1 reference

10.1016/0014-2999(91)90715-3

https://api.crossref.org/works/10.1016/0014-2999(91)90715-3

24 October 2022

Alkylation with beta-funaltrexamine suggests differences between mu-opioid receptor systems in guinea-pig brain and myenteric-plexus

11

1 reference

10.1016/0014-2999(91)90715-3

https://api.crossref.org/works/10.1016/0014-2999(91)90715-3

24 October 2022

Determination of the receptor selectivity of opioid agonists in the guinea-pig ileum and mouse vas deferens by use of beta-funaltrexamine

13

1 reference

10.1016/0014-2999(91)90715-3

https://api.crossref.org/works/10.1016/0014-2999(91)90715-3

24 October 2022

Reversal by beta-funaltrexamine of the antinociceptive effect of opioid agonists in the rat.

14

1 reference

10.1016/0014-2999(91)90715-3

https://api.crossref.org/works/10.1016/0014-2999(91)90715-3

24 October 2022

Opioid delta-receptor involvement in supraspinal and spinal antinociception in mice

15

1 reference

10.1016/0014-2999(91)90715-3

https://api.crossref.org/works/10.1016/0014-2999(91)90715-3

24 October 2022

Selective opioid receptor antagonist effects upon intake of a high-fat diet in rats

16

1 reference

10.1016/0014-2999(91)90715-3

https://api.crossref.org/works/10.1016/0014-2999(91)90715-3

24 October 2022

Autoradiographic study of irreversible binding of [3H]β-funaltrexamine to opioid receptors in the rat forebrain: comparison with μ and δ receptor distribution

22

1 reference

10.1016/0014-2999(91)90715-3

https://api.crossref.org/works/10.1016/0014-2999(91)90715-3

24 October 2022

A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activities

23

1 reference

10.1016/0014-2999(91)90715-3

https://api.crossref.org/works/10.1016/0014-2999(91)90715-3

24 October 2022

Effects of beta-funaltrexamine on radiolabeled opioid binding

24

1 reference

10.1016/0014-2999(91)90715-3

https://api.crossref.org/works/10.1016/0014-2999(91)90715-3

24 October 2022

Microsomal Opiate Receptors: Characterization of Smooth Microsomal and Synaptic Membrane Opiate Receptors

25

1 reference

10.1016/0014-2999(91)90715-3

https://api.crossref.org/works/10.1016/0014-2999(91)90715-3

24 October 2022

Effect of β-FNA on opiate receptor binding: Preliminary evidence for two types of μ receptors

27

1 reference

10.1016/0014-2999(91)90715-3

https://api.crossref.org/works/10.1016/0014-2999(91)90715-3

24 October 2022

Effect of beta-FNA on opiate delta receptor binding.

28

1 reference

10.1016/0014-2999(91)90715-3

https://api.crossref.org/works/10.1016/0014-2999(91)90715-3

24 October 2022

Measurement of protein using bicinchoninic acid

31

1 reference

10.1016/0014-2999(91)90715-3

https://api.crossref.org/works/10.1016/0014-2999(91)90715-3

24 October 2022

Evaluation of delta receptor mediation of supraspinal opioid analgesia by in vivo protection against the beta-funaltrexamine antagonist effect

32

1 reference

10.1016/0014-2999(91)90715-3

https://api.crossref.org/works/10.1016/0014-2999(91)90715-3

24 October 2022

Affinity labels for opioid receptors

33

1 reference

10.1016/0014-2999(91)90715-3

https://api.crossref.org/works/10.1016/0014-2999(91)90715-3

24 October 2022

The irreversible narcotic antagonistic and reversible agonistic properties of the fumaramate methyl ester derivative of naltrexone

34

1 reference

10.1016/0014-2999(91)90715-3

https://api.crossref.org/works/10.1016/0014-2999(91)90715-3

24 October 2022

Comparison of the anticonvulsant effects of opioid peptides and etorphine in rats after ICV administration

36

1 reference

10.1016/0014-2999(91)90715-3

https://api.crossref.org/works/10.1016/0014-2999(91)90715-3

24 October 2022

Effects of beta-funaltrexamine on ingestive behaviors in the rat.

37

1 reference

10.1016/0014-2999(91)90715-3

https://api.crossref.org/works/10.1016/0014-2999(91)90715-3

24 October 2022

Pharmacological profiles of beta-funaltrexamine (beta-FNA) and beta-chlornaltrexamine (beta-CNA) on the mouse vas deferens preparation

39

1 reference

10.1016/0014-2999(91)90715-3

https://api.crossref.org/works/10.1016/0014-2999(91)90715-3

24 October 2022

Opioid receptor binding characteristics of the non-equilibrium mu antagonist, beta-funaltrexamine (beta-FNA).

41

1 reference

10.1016/0014-2999(91)90715-3

https://api.crossref.org/works/10.1016/0014-2999(91)90715-3

24 October 2022

Identifiers

10.1016/0014-2999(91)90715-3

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44334871&oldid=1757001977"